Nanotechnology for Parkinson’s treatment: a novel encapsulation approach allows efficient dopamine delivery to the brain
Read the latest Nanopinion guest column from Dr. Daniel Ruiz-Molina about a novel nanotechnological encapsulation approach to deliver dopamine to the brain. The delivery could be used to treat Parkinson’s disease, which is caused by a deficit of dopamine due to the death of the neurons responsible for its production.
“Alternative strategies to guarantee a continuous supply of dopamine to the brain, without incurring in such complications, is much needed. Nano-encapsulation is being increasingly explored for drug delivery, since smartly-designed nanocarriers can travel throughout the body avoiding the effect of metabolisms and release substances when the desired target is reached.”
Nanopinion is a platform where EUON invites views from different contributors ranging from policy-makers and authorities to industry and civil society on their work and priorities related to nanomaterials on the EU market.
Join the conversation in EUON LinkedIn discussion group
Want to write a Nanopinion post? Contact us